description
Powered by Eupheria Biotech
Quality Level
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
CTGGAGAGCCATTTCCTCAAATGCCCCAAGCCCTCGGCCCAGGAGATCACCTCCCTCGCGGACAGCTTACAGCTGGAGAAGGAGGTGGTGAGAGTTTGGTTTTGTAACAGGAGACAGAAAGAGAAAAGGATGACCCCTCCCGGAGGGACTCTGCCGGGCGCCGAGGATGTGTACGGGGGGAGTAGGGACACTCCACCACACCACGGGGTGCAGACGCCCGTCCAGTGAACTCGAGCTGGGGGAGGGGCAGAGCGCGGGGCTCCCCCTCCCCTTCGGTCCTTGGCCCTTTCCCGGCCCTCTTGTTCCCTCTCTAACTTCTGATTGTTCTTTTATTTTTAATTATTATTTCCCCGTCCCTTAAAAAGACAAAAAAAATAAGGCAAAAGGAAAGCAACTAAGACACTGGACTATCCTTTAAAGGTAGCAGGTGTAATGATGTGTTTTGACCTTTGCAGGCGAGTAAC
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Huei-Yu Chen et al.
Journal of experimental & clinical cancer research : CR, 37(1), 161-161 (2018-07-22)
Oxaliplatin belongs to the platinum-based drug family and has shown promise in treating cancer by binding to DNA to induce cytotoxicity. However, individual patients show diverse therapeutic responses toward oxaliplatin due to yet-unknown underlying mechanisms. We recently established that oxaliplatin
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| EHU041781-20UG | 04061828549443 |
| EHU041781-50UG | 04061828301294 |